Menopausal hormone therapy in women with medical conditions
- 10 September 2021
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 35 (6) , 101578
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (U54 AG044170)
- National Institutes of Health
This publication has 98 references indexed in Scilit:
- Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 UpdateCirculation, 2011
- Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?JACC, 2009
- Estrogen treatment in multiple sclerosisJournal of the Neurological Sciences, 2009
- Gains in Body Fat and Vasomotor Symptom Reporting Over the Menopausal Transition: The Study of Women's Health Across the NationAmerican Journal of Epidemiology, 2009
- Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohortDiabetologia, 2009
- Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologiesDrug Design, Development and Therapy, 2008
- Effects of postmenopausal hormone therapy on rheumatoid arthritis: The women's health initiative randomized controlled trialsArthritis Care & Research, 2008
- More Similarities Than Differences: An International Comparison of CVD Mortality and Risk Factors in WomenHealth Care for Women International, 2007
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow upBJOG: An International Journal of Obstetrics & Gynaecology, 1997